Lipid Lowering Agents and the Endothelium: An Update after 4 Years

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|10|1|33-41

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.10, Iss.1, 2012-01, pp. : 33-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ezetimibe; More Than a Low Density Lipoprotein Cholesterol Lowering Drug? An Update After 4 Years

By  

Current Vascular Pharmacology, Vol. 9, Iss. 1, 2011-01 ,pp. : 62-86

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid-Lowering Agents and the Risk of Cognitive Impairment That Does Not Meet Criteria for Dementia, in Relation to Apolipoprotein E Status

By  

Neuroepidemiology, Vol. 29, Iss. 3-4, 2007-11 ,pp. : 201-207

Karger

Access to resources Recommend Favorite

Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders

By  

Current Vascular Pharmacology, Vol. 14, Iss. 3, 2016-05 ,pp. : 280-287

Bentham Science Publishers

Access to resources Recommend Favorite

AVA Update - AVA: Two Years after the Name Change

By Nations Mary Lea  

Journal of the Association for Vascular Access, Vol. 10, Iss. 3, 2005-0 ,pp. : 98-101

Association of University Programs in Health Administration

Access to resources Recommend Favorite

Platelet function and lipid-lowering interventions

By Milionis Haralampos J.   Elisaf Moses S.   Mikhailidis Dimitri P.  

Platelets, Vol. 10, Iss. 6, 1999-12 ,pp. : 357-367

Informa Healthcare

Access to resources Recommend Favorite